Sheldon L. Koenig

Insider Reports History

Entity
Individual
Location
C/O Portola Pharmaceuticals, Inc., 270 East Grand Avenue, South San Francisco, CA
Signature
/s/ Sheldon L. Koenig
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sheldon L. Koenig:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Esperion Therapeutics, Inc. President and CEO, Director Common Stock 752K $1.35M $1.80 Sep 17, 2024 Direct
Esperion Therapeutics, Inc. President and CEO, Director Stock Option (right to buy) 642K $1.04M $1.62 Mar 14, 2024 Direct

Insider Reports Filed by Sheldon L. Koenig

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ESPR Esperion Therapeutics, Inc. Sep 17, 2024 1 -$26.1K 4 Sep 18, 2024 President and CEO, Director
ESPR Esperion Therapeutics, Inc. Mar 14, 2024 2 $0 4 Mar 15, 2024 President and CEO, Director
ESPR Esperion Therapeutics, Inc. May 9, 2023 1 $25.2K 4 May 10, 2023 President and CEO, Director
ESPR Esperion Therapeutics, Inc. Mar 17, 2023 1 -$12.5K 4 Mar 20, 2023 President and CEO, Director
ESPR Esperion Therapeutics, Inc. Mar 14, 2023 2 $0 4 Mar 15, 2023 President and CEO, Director
ESPR Esperion Therapeutics, Inc. Mar 7, 2023 1 -$27.5K 4 Mar 8, 2023 President and CEO, Director
ESPR Esperion Therapeutics, Inc. Sep 19, 2022 1 -$23.5K 4 Sep 20, 2022 President and CEO, Director
ESPR Esperion Therapeutics, Inc. Aug 5, 2022 1 $50K 4 Aug 8, 2022 President and CEO, Director
ESPR Esperion Therapeutics, Inc. Jun 17, 2022 1 -$22.7K 4 Jun 21, 2022 President and CEO, Director
ESPR Esperion Therapeutics, Inc. Jun 7, 2022 1 $0 4 Jun 9, 2022 President and CEO, Director
ESPR Esperion Therapeutics, Inc. Mar 17, 2022 1 -$2.62K 4 Mar 18, 2022 President and CEO, Director
ESPR Esperion Therapeutics, Inc. Mar 14, 2022 1 $0 4 Mar 16, 2022 President and CEO, Director
ESPR Esperion Therapeutics, Inc. Oct 29, 2021 1 $0 4 Nov 1, 2021 President and CEO, Director
ESPR Esperion Therapeutics, Inc. May 17, 2021 2 $0 4 May 18, 2021 President and CEO, Director